Is this the likely customer !10 Aug 2020 12:14
Sponsoring organisation: Janssen Vaccines & Prevention B.V https://www.janssen.com/ A Randomized, Double-blind, Phase 1/2a Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.preF in Adults 18 to 50 Years of Age and RSV-Seropositive Toddlers 12 to 24 Months of AgeYou are invited to take part in a study to investigate a new vaccine against Respiratory Syncytial Virus (RSV), a highly infectious respiratory virus that infects the lungs and breathing passages. The study is being run by the Oxford Vaccine Group at the University of Oxford.If you are 18 to 50 yrs old and are in good health then you may be eligible to take part in this study. We will provide reimbursement for your time, inconvenience and travel.